Skip to main content
. 2022 Oct;43(10):1508–1515. doi: 10.3174/ajnr.A7637

Table 2:

Multivariable linear mixed-effects modeling of CBF based on clinical, demographic, and study factorsa

Mod_Baseline Mod_HCP Mod_HCPCMS
(Intercept) 43.3 (3.86)b 48.4 (4.06)b 50.1 (4.70)b
Postop time point 6.21 (2.00)c 3.01 (2.08) 1.55 (2.20)
Follow-up time point 14.8 (2.07)b 10.5 (2.15)b 7.74 (2.31)b
Age −0.686 (0.45) −1.17 (0.53)d −1.34 (0.59)d
Thalamus −5.55 (1.60)b −5.59 (1.51)b −5.60 (1.45)b
Cerebellum −10.0 (1.59)b −10.0 (1.50)b –10.0 (1.44)b
Unsedated (vs GA) 3.57 (3.79) 5.73 (3.93)
Hydrocephalus −19.4 (6.04)c −20.5 (6.27)c
Postop time point + HCP 21.5 (5.17)b 24.0 (5.13)b
Follow-up time point + HCP 26.0 (5.22)b 27.2 (5.18)b
CMS −10.9 (6.46)e
Postop time point + CMS 8.74 (5.26)e
Follow-up time point + CMS 15.6 (5.28)c
AIC 1841.5 1824.7 1821.8
Marginal R2 0.224 0.290 0.295
Conditional R2 0.607 0.650 0.692

Note:—– indicates not included in model; GA, general anesthesia; Post-op, postoperative.

a

Values are coefficients (standard error).

b

P < .001.

c

P < .01.

d

P < .05.

e

P < .1.